Follow-up Duration : While trials extend to 72 weeks or longer, the chronic nature of obesity requires decades-long, unavailable safety and efficacy data
Its especially helpful for first-time GLP-1 users
[1] If side effects significantly impair your quality of life despite timing adjustments, your prescriber may consider dose modification or alternative treatment options
These pathways are often reviewed in laboratory models involving metabolic signalling, receptor interaction, glucose response, energy balance and appetite-related signalling
Rotating Injection Sites to Reduce Skin Reactions Rotating injection sites moving at least 12 cm from the previous spot and alternating between body regions prevents lipohypertrophy and ensures consistent drug absorption
In one study, non-diabetic GLP-1 users who maintained stable weights had a 22% higher osteoporosis risk compared to those on other weight loss medications